Nathan Higa, DPM
Podiatrist · Aiea, HINPI 1235366477
Payments from drug & device makers
What this record shows
This record is dominated by other: $2,465 of the $3,318 with a category attached, or 74.3%. Smith+Nephew accounts for 81.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $2,508 and has fallen 94.7% since, to $134 in 2025.
Across 23 payments — averaging $144.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Orthofix Medical, Inc.$184
- Anika Therapeutics, Inc.$88
- KCI USA, Inc.$74
- Melinta Therapeutics, LLC$71
- Bone Support Inc.$62
- plus $152 from 5 others
What the payments were for
- Food & beverage$85326%
- Other$2,46574%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 9 | $2,687 |
| Orthofix Medical, Inc. | 5 | $184 |
| Anika Therapeutics, Inc. | 1 | $88 |
| KCI USA, Inc. | 1 | $74 |
| Melinta Therapeutics, LLC | 1 | $71 |
| Bone Support Inc. | 1 | $62 |
| Johnson & Johnson | 1 | $46 |
| Averitas Pharma Inc. | 1 | $44 |
| Zimmer Biomet | 1 | $25 |
| Stryker | 1 | $19 |
| Osiris Therapeutics Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRAFIX PL$2,589
How this compares
Too few podiatrist providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 29 | $671 |
| Mupirocin | 15 | $86 |
| Meloxicam | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Aiea
- Attilio AvinoAiea$517
- Michael ChunAiea$431
- Cindy HicksAiea$24
- Robert AkiEwa Beach$6K
- Brian SugaiHilo$3K
- Andrew ChengHonolulu$2K
- Douglas BirchKahului$1K
- Kenson MiyakiHonolulu$1K
- Christopher YeeHonolulu$320
- Tyler ChiharaLihue$285
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.